Updated Jul 16, 2026
Roberts M Scot is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
M Scot Roberts is the Chief Scientific Officer at Altimmune, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's efforts to advance its investigational therapies, including pemvidutide.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-03 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 2.3K | $5.55 | $13K |
| 2026-02-03 | ALT | Altimmune, Inc. | M — Option exercise | 7.8K | $0.00 | |
| 2026-02-03 | ALT | Altimmune, Inc. | A — Grant or award | 5.6K | $3.07 | $17K |
| 2026-02-03 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 2.9K | $5.60 | $16K |
| 2026-02-03 | ALT | Altimmune, Inc. | M — Option exercise | 9.3K | $0.00 | |
| 2026-01-29 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 4.7K | $6.18 | $29K |
| 2026-01-29 | ALT | Altimmune, Inc. | M — Option exercise | 15.8K | $0.00 | |
| 2026-01-27 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 4.4K | $5.50 | $24K |
| 2026-01-27 | ALT | Altimmune, Inc. | M — Option exercise | 14.6K | $0.00 | |
| 2025-07-31 | ALT | Altimmune, Inc. | A — Grant or award | 846 | $3.14 | $3K |
M Scot Roberts is the Chief Scientific Officer at Altimmune, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's efforts to advance its investigational therapies, including pemvidutide.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Roberts M Scot profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.